Sign In
Buy TMO
$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast flagship Advanced Therapies Collaboration Cente
Final Trades: UnitedHealth, Thermo Fisher, Monster Beverage and the IYH
01:51pm, Monday, 17'th Nov 2025
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher Scientific Launches CorEvitas Clinical Registry in Myasthenia Gravis, a Rare Autoimmune Disorder
10:03am, Monday, 17'th Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in the new PPD™ CorEvitas™ Myasthenia Gravi
Bulltick Wealth Management LLC Boosts Holdings in Thermo Fisher Scientific Inc. $TMO
05:03am, Monday, 17'th Nov 2025
Bulltick Wealth Management LLC lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 495.0% in the undefined quarter, according to its most recent Form 13F filing with the Secu
Thermo Fisher Scientific Inc. $TMO Shares Sold by Alberta Investment Management Corp
03:30am, Monday, 17'th Nov 2025
Alberta Investment Management Corp reduced its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 67.7% in the undefined quarter, according to the company in its most recent 13F filing wi
Larry Robbins Reduces Stake in Tenet Healthcare Corp by 20.69%, Impacting Portfolio by -2.99%
05:08pm, Friday, 14'th Nov 2025
Insights from Glenview Capital Management's Third Quarter 2025 13F Filing Larry Robbins (Trades, Portfolio) recently submitted the 13F filing for the third qua
Artisan Value Fund Q3 2025 Top Contributors And Detractors
12:50pm, Friday, 14'th Nov 2025
Our biggest source of underperformance was the consumer staples sector as we had a number of laggards, including Kerry Group, Philip Morris and Diageo. On the positive side, the three new purchases we
First Pacific Advisors' Strategic Moves: Becton Dickinson & Co Takes Center Stage
06:01pm, Thursday, 13'th Nov 2025
Exploring the Latest 13F Filing for Q3 2025 First Pacific Advisors (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, providi
Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway
01:51pm, Thursday, 13'th Nov 2025
The Investment Committee give you their top stocks to watch for the second half.
The Big 3: TMO, DHR, VLO
12:50pm, Thursday, 13'th Nov 2025
As A.I. stocks take a beating on Wednesday's trading session, Dan Deming offers his thoughts and example options trades in healthcare and energy stocks. He explains his bullish theses behind Thermo Fi
Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma
08:00am, Wednesday, 12'th Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced 510(k) clearance of the EXENT® Analyser and Immunoglobulin Isotypes (G
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
04:35pm, Thursday, 06'th Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion
Thermo Fisher Scientific Declares Quarterly Dividend
04:30pm, Thursday, 06'th Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.
Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities
01:04pm, Wednesday, 29'th Oct 2025
Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other
Thermo Fisher Scientific to acquire Clario in $8.9B cash deal
11:22am, Wednesday, 29'th Oct 2025
Thermo Fisher Scientific Inc (NYSE:TMO, ETR:TN8) announced on Wednesday that it has agreed to acquire Clario Holdings Inc, a provider of endpoint data solutions for clinical trials, for $8.875 b
